MYUDA Trademark

Trademark Overview

On Friday, March 16, 2012, a trademark application was filed for MYUDA with the United States Patent and Trademark Office. The USPTO has given the MYUDA trademark a serial number of 85571369. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 6, 2022. This trademark is owned by Glaxo Group Limited. The MYUDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
myuda

General Information

Serial Number85571369
Word MarkMYUDA
Filing DateFriday, March 16, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 6, 2022
Registration Number4834279
Registration DateTuesday, October 20, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word(s) "MYUDA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, May 6, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, October 20, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 20, 2015REGISTERED-PRINCIPAL REGISTER
Monday, September 14, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, September 10, 2015NOTICE OF ALLOWANCE CANCELLED
Thursday, September 10, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015SOU EXTENSION 5 GRANTED
Friday, March 27, 2015SOU EXTENSION 5 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014SOU EXTENSION 4 GRANTED
Tuesday, September 30, 2014SOU EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014SOU EXTENSION 3 GRANTED
Monday, March 31, 2014SOU EXTENSION 3 FILED
Monday, March 31, 2014TEAS EXTENSION RECEIVED
Tuesday, October 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2013SOU EXTENSION 2 GRANTED
Wednesday, September 18, 2013SOU EXTENSION 2 FILED
Wednesday, October 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Friday, March 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 27, 2013SOU EXTENSION 1 GRANTED
Wednesday, March 27, 2013SOU EXTENSION 1 FILED
Wednesday, March 27, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 2, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 7, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 3, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 27, 2012DATA MODIFICATION COMPLETED
Monday, June 25, 2012DATA MODIFICATION COMPLETED
Monday, June 25, 2012ASSIGNED TO LIE
Saturday, June 23, 2012ASSIGNED TO EXAMINER
Monday, March 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

myuda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological